BFC Planning’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
BFC Planning's HAE Position: Q3 2026 in Review
BFC Planning sold out of Haemonetics (HAE) in Q3 2026, closing a stake of 12 shares — an estimated $900 sold.
BFC Planning first reported a position in HAE in Q2 2026 and held it in 1 quarter. The position peaked at $900 in Q2 2026. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- BFC Planning reported no remaining Haemonetics position as of Q3 2026 after selling out during the quarter.
- BFC Planning sold 12 Haemonetics shares in Q3 2026, an estimated $900.
- BFC Planning first reported a position in Haemonetics in Q2 2026 and held it in 1 quarter.
- BFC Planning's Haemonetics position peaked at $900 in Q2 2026.
- 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.